Jonathan Behr

DDF Partner

Jon brings over 10 years of venture and venture creation experience to the DDF including as managing director of a mission driven fund.

Jon joined the DDF as Partner in July of 2019

Prior experience

Jon joins the DDF from the JDRF T1D Fund, a growing $75 million mission-driven fund focused on venture investments in companies developing solutions for type 1 diabetes, where he joined at inception as the fund’s first managing director.  He led the development of the fund’s investment strategy with the board of directors, built an investment team, and led 14 of the fund’s first investments. Prior to the JDRF T1D Fund, Jon was a Market Sector Leader and Executive in Residence at Partners Healthcare Innovation, leading a team responsible for driving technology translation from research hospitals affiliated with Harvard Medical School.  His areas of responsibility included neuroscience, and successes included Tilos Therapeutics. He has held senior venture creation roles, including Principal at PureTech Ventures (PRTC) and Vice President of New Ventures for Enlight Biosciences. In these roles he co-founded and supported seven companies and took senior operating roles in several. In all his prior roles he was a director or observer on more than 14 companies including Provention Bio (PRVB), Semma Therapeutics, AntolRx, Exosome Diagnostics, Entrega Inc. ,and Tiaki Therapeutics.

Academic credentials

Jon has a Ph.D. in Biological Engineering from Massachusetts Institute of Technology as a Howard Hughes Medical Institute fellow, and received his B.S. in Bioengineering summa cum laude as phi-beta-kappa co-valedictorian from Rice University.

Team
DDF Leadership

Office
Boston